ACKR3 and cancer: In the case of ACKR3, the finding that RAMPs can diminish receptor internalization and ligand scavenging presents a valuable opportunity to stabilize this interaction as a novel therapeutic strategy for pain management (5, 54) and against cancer (55, 56).